TABLE 3.
Characteristics a | 2019 | 2020 | p value |
---|---|---|---|
n = 104 | n = 114 | ||
Testing Results (%) | .91 | ||
Positive | 30 (29) | 32 (28) | – |
Variant of uncertain significance | 34 (33) | 35 (31) | – |
Negative | 40 (38) | 47 (41) | – |
Indication for testing (%) | <.001 | ||
Familial pathogenic variant | 19 (18) | 43 (38) | – |
Nonischemic cardiomyopathy | |||
Hypertrophic cardiomyopathy | 35 (34) | 15 (13) | – |
Dilated cardiomyopathy | 4 (4) | 12 (11) | – |
Other nonischemic cardiomyopathies | 8 (8) | 14 (12) | – |
Abnormal lipids | 16 (15) | 7 (6) | – |
Aortic pathology | 9 (11) | 9 (8) | – |
Abnormal electrocardiogram | 4 (4) | 9 (8) | – |
Sudden cardiac arrest | 4 (4) | 1 (1) | – |
Connective tissue disease | 2 (2) | 0 (0) | – |
Syncope | 1 (1) | 1 (1) | – |
Family history of sudden cardiac arrest | 1 (1) | 2 (2) | – |
Muscular dystrophy | 1 (1) | 1 (1) | – |
Data were expressed as number (percentage).